Virtual Systems Pharmacology (ViSP) software for mechanistic system-level model simulations

Frontiers in Pharmacology

Derek eBartlett¹  Tarek A Leil¹  Sergey eErmakov²  Jyotsna ePagidala²  Albert eWang²  Marko eMiladinov²  Peter eForster³  Mike eReed⁴  Rebecca eBaillie⁴ 

[1] Co, LLC;Bristol-Myers Squibb;Forster Solutions, LLC;;Rosa &

关键词: virtual patient;    Quantitative Systems Pharmacology;    simulation experiment;    system-level mechanistic models;    model development software;    metabolic diseases model;   

DOI  :  10.3389/fphar.2014.00232

来源: DOAJ

【 摘 要 】

Multiple software programs are available for designing and running large scale system-level pharmacology models used in the drug development process. Depending on the problem, scientists may be forced to use several modeling tools that could increase model development time, IT costs and so on. Therefore it is desirable to have a single platform that allows setting up and running large-scale simulations for the models that have been developed with different modeling tools. We developed a workflow and a software platform in which a model file is compiled into a self-contained executable that is no longer dependent on the software that was used to create the model. At the same time the full model specifics is preserved by presenting all model parameters as input parameters for the executable. This platform was implemented as a model agnostic, therapeutic area agnostic and web-based application with a database back-end that can be used to configure, manage and execute large-scale simulations for multiple models by multiple users. The user interface is designed to be easily configurable to reflect the specifics of the model and the user’s particular needs and the back-end database has been implemented to store and manage all aspects of the systems, such as Models, Virtual Patients, User Interface Settings, and Results. The platform can be adapted and deployed on an existing cluster or cloud computing environment. Its use was demonstrated with a metabolic disease systems pharmacology model that simulates the effects of two antidiabetic drugs, metformin and fasiglifam, in type 2 diabetes mellitus patients.

【 授权许可】

Unknown